Placental mast cell heterogeneity in pregnancy complicated by diabetes class C

Inflammation Research

Volumn 49, Issue SUPPL. 1, 2000, Pages

  Szukiewicz, D ^a   Maslinska, D ^b   Poppe, P ^a   Gujski, M ^a   Tomecki, A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

CELL COUNT; CELL HETEROGENEITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; MAST CELL; PLACENTA; PREGNANCY;

EID: 0034023150     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00000170     Document Type: Conference Paper

References (8)

1. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997; 61: 233-45.
2. Toru H, Mitsuoki E, Matsumoto R, Yanagida M, Yata J, Nakahata T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998; 91: 187-95.
3. Schwartz LB, Irani AA, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 1987; 138: 2611-5.
4. Purcell WM, Hanahoe TH. A novel source of mast cells: the human placenta. Agents Actions 1991; 33: 8-12.
5. Mikkelsen AL, Felding C, Larsen LG. Mast cells in the placenta. Is there a relation to the development of atopic disease in infants before 18 month of age? J Perinat Med 1994; 22: 273-77.
6. Szukiewicz D, Szukiewicz A, Maslinska D, Markowski MW. Placental mast cells (MC) and histamine (HA) in pregnancy complicated by diabetes class C - relation to the development of villous microvessels. Trophoblast Res 1999; 13: 503-10.
7. White P. Classification of obstetric diabetes. Am J Obstet Gynecol 1978; 130: 228-30.
8. Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 1997; 72: 385-8.